Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Option Award |
2025-02-03 6:38 pm |
N/A 2035-02-03 |
Boundless Bio Inc. | BOLD | Doebele Robert Chief Medical Officer |
180,000 | $0 | 180,000 (Direct) |
View |
| 2024-01-26 Equity Swap |
2024-01-26 4:36 pm |
N/A N/A |
Rain Oncology Inc. | RAIN | Doebele Robert See Remarks |
476,827 | $0 | 0 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 9:16 pm |
N/A 2033-08-09 |
Rain Oncology Inc. | RAIN | Doebele Robert See Remarks |
149,100 | $0 | 149,100 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 6:18 pm |
N/A 2033-02-15 |
Rain Oncology Inc. | RAIN | Doebele Robert See Remarks |
123,325 | $0 | 123,325 (Direct) |
View |
| 2022-07-06 Exercise |
2022-07-07 6:02 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks |
3,890 | $3.95 | 481,827 (Direct) |
View |
| 2022-07-06 Exercise |
2022-07-07 6:02 pm |
N/A 2029-03-13 |
Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks |
3,890 | $0 | 481,827 (Direct) |
View |
| 2022-04-13 Exercise |
2022-04-15 4:30 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks |
3,000 | $3.95 | 481,827 (Direct) |
View |
| 2022-04-13 Exercise |
2022-04-15 4:30 pm |
N/A 2029-03-13 |
Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks |
3,000 | $0 | 481,827 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 4:15 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks |
2,000 | $3.95 | 481,827 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 4:15 pm |
N/A 2029-03-13 |
Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks |
2,000 | $0 | 481,827 (Direct) |
View |
| 2022-01-07 Option Award |
2022-02-04 4:35 pm |
N/A 2032-01-07 |
Rain Therapeutics Inc. | RAIN | Doebele Robert EVP, Chief Scientific Officer |
72,000 | $0 | 72,000 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-27 5:04 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Doebele Robert EVP, Chief Scientific Officer |
10,259 | $0 | 467,937 (Direct) |
View |
Ownership |
2021-04-22 7:12 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Doebele Robert EVP, Chief Scientific Officer |
0 | $0 | 606,838 (Direct) |
View |